Controlled trial of Hartmann's solution versus 0.9% saline for diabetic ketoacidosis

Journal of Paediatrics and Child Health

Volumn 53, Issue 1, 2017, Pages 12-17

  Yung, Michael ^a   Letton, Georgia ^a   Keeley, Steve ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

Author keywords

diabetic ketoacidosis; intravenous infusion; metabolic acidosis

Indexed keywords

BICARBONATE; GLUCOSE; HARTMANN SOLUTION; INSULIN; SODIUM CHLORIDE; SODIUM ION;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD GAS; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; DEHYDRATION; DIABETIC KETOACIDOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESUSCITATION; SODIUM BLOOD LEVEL; TREATMENT OUTCOME; ADOLESCENT; CHILD; FLUID THERAPY;

ADOLESCENT; CHILD; DIABETIC KETOACIDOSIS; DOUBLE-BLIND METHOD; FEMALE; FLUID THERAPY; HUMANS; MALE; SODIUM CHLORIDE;

EID: 85009164716     PISSN: 10344810     EISSN: 14401754     Source Type: Journal    
DOI: 10.1111/jpc.13436     Document Type: Article

References (14)

1. Australasian Paediatric Endocrine Group for the Department of Health and Aging. Clinical Practice Guidelines: Type 1 Diabetes in Children and Adolescents. Canberra: Commonwealth of Australia; 2005. Available from: http://www.nhmrc.gov.au/_files_nhmrc/file/publications/synopses/cp102.pdf [accessed 21 October 2010].
2. Wolfsdorf J, Craig ME, Daneman D et al. ISPAD clinical practice consensus guidelines 2006-2007 diabetic ketoacidosis. Pediatr. Diabetes 2007; 8: 28–43.
3. Hartmann A, Darrow D. The composition of the plasma in severe diabetic ketoacidosis and the changes taking place during recovery. J. Clin. Invest. 1928; 6: 257–76.
4. Kydd D. Salt and water in the treatment of diabetic ketoacidosis. J. Clin. Invest. 1933; 12: 1169–83.
5. Adrogue H, Wilson H, Boyd A, Suki W, Eknoyan G. Plasma acid-base patterns in diabetic ketoacidosis. N. Engl. J. Med. 1982; 307: 1603–10.
6. Adrogue H, Eknoyan G, Suki W. Diabetic ketoacidosis: Role of the kidney in the acid-base homeostasis re-evaluated. Kidney Int. 1984; 25: 591–8.
7. Hartmann AF, Elman R, with the Technical Assistance of Marie Morton. The effects of loss of gastric and pancreatic secretions and the methods for restoration of normal conditions in the body. J. Exp. Med. 1929; 50: 387–405.
8. Waters J, Gottlieb A, Schoenwald P, Popovich M, Sprung J, Nelson D. Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysm repair: An outcome study. Anesth. Analg. 2001; 93: 817–22.
9. Williams E, Hildebrand K, McCormick S, Bedel M. The effect of intravenous lactated Ringer's solution versus 0.9% sodium chloride solution on serum osmolality in human volunteers. Anesth. Analg. 1999; 88: 999–1003.
10. McFarlane C, Lee A. A comparison of Plasmalyte 148 and 0.9% saline for intra-operative fluid replacement. Anaesthesia 1994; 49: 779–81.
11. Yunos N, Bellomo R, Hegarty C, Story D, Ho L, Bailey M. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012; 308: 1566–72.
12. Koves IH, Neutze J, Donath S et al. The accuracy of clinical assessment of dehydration during diabetic ketoacidosis in childhood. Diabetes Care 2004; 27: 2485–7.
13. Antunes-Rodrigues J, de Castro M, Elias L, Valenca M, McCann S. Neuroendocrine control of body fluid metabolism. Physiol. Rev. 2004; 84: 169–208.
14. Chua H-R, Venkatesh B, Stachowski E et al. Plasma-Lyte 148 vs 0.9% saline for fluid resuscitation in diabetic ketoacidosis. J. Crit. Care 2012; 27: 138–45.